Benjamin M. Daniels is a special counsel and business lawyer with Foley & Lardner LLP. He focuses his practice in the health care field, and has in-depth knowledge of federal and state regulation of laboratories, the drug and device supply chain, and pharmacies.
He advises health care providers, investors, and lenders on transactional matters and regulatory compliance, including mergers and acquisitions, recapitalizations, buyouts, restructurings, joint ventures, and broad range of commercial transactions.
Ben also advises clients on a wide range of health care regulatory matters, including compliance, government investigations, reimbursement, licensure, and research operations. He is a member of the firm’s Health Care Practice as well as the firm’s Health Care Industry Team.
Prior to returning to Foley, Ben served as Assistant General Counsel at Fresenius Kidney Care, where he counselled several Fresenius business lines that complement the company’s core dialysis focus, including its laboratory, pharmacy, wholesale drug and device distribution, and operations.
His imbedded experience allows Ben to understand and carefully balance the business goals of his clients with the complex regulatory environments in which they operate.
Ben’s work covers a wide range of pharmacy matters including:
- Retail and Specialty Pharmacies: Represented numerous retail and specialty pharmacies on regulatory issues, including state Boards of Pharmacy inspection and adverse findings, compounding pharmacy matters, and licensure among others. Represented investors both venture capital and private equity) in pharmacy investments, acquisitions and sales.
- Prescription Drug Supply Chain – Wholesalers and Third Party Logistic Providers: Represented prescription drug and device wholesalers and third party logistics providers on a variety of issues related to regulatory compliance, licensing, and transactions.
- Telepharrmacy and Digital Health: Ben advises suppliers, providers, consultants, vendors, and a variety of other health care entities on a range of business, legal, and regulatory issues affecting the telemedicine industry. He advises on controlled substance prescribing, multi-state licensure, practice of pharmacy restrictions and regulations, direct to consumer medication sales, patient freedom of choice, and state and federal fraud and abuse considerations.
Ben graduated from Boston College Law School (J.D., cum laude, 2010). While in law school, he worked at the Boston College Legal Assistance Bureau’s Community Enterprise Clinic as a student attorney, providing legal advice and consultation to individual and non-profit clients on a range of legal matters. Ben also earned his Bachelor of Arts in political science (summa cum laude, 2005) and his Master of Public Policy (2006) from The George Washington University.
Ben is admitted to practice in Massachusetts.
Rate : $$$